The Health Committee welcomes the Government's decision to commission two reviews following public concern about breast implant surgery, following the decision of the French authorities to recommend removal of implants sourced from PIP. The first, led by Sir Bruce Keogh, is tasked with assessing the regulation of cosmetic interventions in general. The second, led by Earl Howe, is tasked with analysing the policy reaction, in particular by MHRA and DoH, to the announcement by the French authorities in March 2010 that PIP products did not comply with the requirements of their CE registration. Sir Bruce 's preliminary report concluded that there is no evidence of likely long term negative health effects attributable to PIP implants, though the quality of evidence available does not allow definitive conclusions to be drawn. The Committee welcomes the Government's undertaking that the NHS will remove and replace any NHS implant which has failed, and agrees with the Government that all other care providers should make the same offer. The cost of all care provided in respect of non-NHS implants should be recovered, where possible, from the original care provider, or their insurers. Earl Howe's review should focus on key policy issues: the quality of information available about devices that have been implanted into patients; evidence that MRHA notices withdrawing CE registration from individual products do not require any positive response from non-NHS users of those products; evidence that some patients may have received implants without being fully aware of the medium and long term consequences.